Pendal Group LTD Pfizer Inc Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Pfizer Inc stock. As of the latest transaction made, Pendal Group LTD holds 218,255 shares of PFE stock, worth $5.83 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

218,255

Previous 177,442 23.0%

Holding current value

$5.83 Million

Previous $7.77 Million 44.07%

% of portfolio

0.09%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $1.7 Million - $2.22 Million	40,813 Added 23.0%	218,255 $0
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $858,483 - $1.05 Million	-19,618 Reduced 9.96%	177,442 $7.77 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $2.69 Million - $3.19 Million	-57,866 Reduced 22.7%	197,060 $10.3 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $1.15 Million - $1.42 Million	25,083 Added 10.91%	254,926 $13.2 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $422,083 - $625,668	-10,215 Reduced 4.26%	229,843 $13.6 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $3.69 Million - $4.74 Million	-93,946 Reduced 28.13%	240,058 $10.3 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $1.92 Million - $2.18 Million	53,470 Added 19.06%	334,004 $13.1 Million
Q1 2021 May 24, 2021	BUY	$33.49 - $37.77 $9.4 Million - $10.6 Million	280,534 New	280,534 $10.2 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $9.46 Million - $10.7 Million	-282,331 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $4.77 Million - $6.07 Million	-142,514 Reduced 33.54%	282,331 $10.4 Million
Q3 2020 Nov 02, 2020	SELL	$31.75 - $37.25 $5.04 Million - $5.91 Million	-158,776 Reduced 27.21%	424,845 $15.6 Million
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $1.99 Million - $2.41 Million	66,038 Added 12.76%	583,621 $19.1 Million
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $679,534 - $970,906	25,140 Added 5.11%	517,583 $16 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $501,503 - $569,142	-15,234 Reduced 3.0%	492,443 $18.3 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $1.94 Million - $2.52 Million	-59,852 Reduced 10.55%	507,677 $17.3 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $8.68 Million - $9.74 Million	-234,688 Reduced 29.25%	567,529 $0
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $4.05 Million - $4.45 Million	108,021 Added 15.56%	802,217 $0
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $4.51 Million - $5.15 Million	117,307 Added 20.33%	694,196 $28.7 Million
Q3 2018 Nov 05, 2018	BUY	$34.47 - $41.81 $8.43 Million - $10.2 Million	244,696 Added 73.66%	576,889 $0
Q2 2018 Jul 18, 2018	BUY	$32.98 - $35.16 $2.33 Million - $2.48 Million	70,606 Added 26.99%	332,193 $0
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $13.1 Million - $15.2 Million	-411,829 Reduced 61.16%	261,587 $0
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $723,970 - $768,157	-21,767 Reduced 3.13%	673,416 $0
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $6.68 Million - $7.36 Million	215,641 Added 44.97%	695,183 $0
Q2 2017 Aug 11, 2017	BUY	N/A	479,542	479,542 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account